Trastuzumab deruxtecan plus pertuzumab as a substantial advancement in previously untreated patients with HER2-positive metastatic breast cancer.
Year: 2026
Type: article
Study designs: Systematic Review, Meta-Analysis
Source: PubMed
Institution: Regione Toscana
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204887613